Florida Medical Marijuana Business Licenses & Regulations
Medical Marijuana
In November 2016, Florida voters approved Amendment 2, legalizing medical marijuana. This amendment expanded the medical conditions eligible for treatment with marijuana under Florida law, significantly broadening the scope of the medical marijuana program established by previous legislation in 2014. The Florida Department of Health, through its Office of Medical Marijuana Use (OMMU), oversees the state’s medical marijuana program. OMMU is responsible for the registration of patients and the regulation of medical marijuana treatment centers (MMTCs). It ensures compliance with state laws, processes medical and business license applications, and enforces medical marijuana regulations across Florida.
Florida offers several different types of medical marijuana business licenses, which include the following:
- Medical Marijuana Treatment Centers (MMTCs) – MMTCs in Florida are vertically integrated businesses responsible for the cultivation, processing, and dispensing of medical marijuana as stipulated under Florida Statute § 381.986. To operate, MMTCs must demonstrate their ability to handle comprehensive health and treatment facilities, secure resources for full-scale operations, and meet the rigorous standards set forth by the Office of Medical Marijuana Use (OMMU). Applicants must also comply with the criteria established in the Medical Marijuana Act, which governs the entire scope of medical marijuana operations from seed to sale.
- Cultivation – MMTCs are the only entities authorized to cultivate marijuana as part of their integrated operations, regulated under Florida Statute § 381.986-8. They must ensure that security measures and cultivation practices adhere to the strict guidelines set by the OMMU. Florida currently caps the number of MMTC licenses, making them a highly sought-after and competitive market.
- Dispensary – MMTCs operate dispensaries that provide medical marijuana to qualified patients and their caregivers. The number of dispensary facilities an MMTC can operate is directly regulated by the OMMU and is subject to changes based on patient population and regional healthcare needs as outlined in Florida Statute § 381.986-14.
- Transporter – MMTCs are licensed to transport medical marijuana between their facilities and directly to patients when necessary, as part of their comprehensive license. All transport operations must adhere to safety and compliance regulations under Florida Statute § 381.986-11, ensuring secure transport of cannabis products across the state.
Testing – While independent testing is not mandated, MMTCs must conduct internal quality assurance tests to ensure their products meet state safety standards. The OMMU enforces these standards through random tests and inspections, guided by the parameters set in Florida Statute § 381.986-9.
Hemp
Hemp was federally legalized by the Agriculture Improvement Act of 2018, commonly known as the 2018 Farm Bill, which removed hemp (defined as cannabis with less than 0.3% THC) from the Schedule I controlled substances list. In Florida, hemp is governed under Florida Statutes § 581.217, also known as the “State Hemp Program Act.” This act was established to provide guidelines for the cultivation, processing, and sale of hemp within the state. The Florida Department of Agriculture and Consumer Services (FDACS) oversees the hemp program. FDACS issues licenses for cultivation, processing, and selling hemp products and ensures that all hemp products sold in Florida meet state and federal regulations.
- Cultivation – Under Florida Statutes § 581.217, individuals and businesses interested in cultivating hemp must obtain a license from FDACS. The application process includes background checks, detailed descriptions of cultivation sites, and compliance plans for the storage and transportation of hemp. Cultivators must ensure that their hemp crops do not exceed the THC threshold of 0.3%, which requires regular testing and monitoring.
- Processing and Sale – Processing hemp into products, especially those containing cannabinoids like CBD and minor cannabinoids such as Delta-8 THC, requires adherence to specific state guidelines. Florida has taken a cautious approach to regulating minor cannabinoids, particularly due to the psychoactive effects associated with Delta-8 THC. As of the latest updates, Florida aligns with federal regulations, which do not distinctly classify Delta-8 THC as illegal but require that it must not be synthetically derived from non-hemp sources.
- Delta-8 THC Regulation – Recent scrutiny over Delta-8 THC has led to legislative reviews in Florida. While not explicitly banned, Delta-8 products must be derived from legal hemp and contain less than 0.3% Delta-9 THC. The FDACS has the authority to conduct random testing of hemp products sold in the state to ensure compliance with the law, as stipulated under Florida Administrative Code Rule 5K-4.034.
- Retail and Consumer Safety – Retailers selling hemp products in Florida are required to ensure that products are properly labeled with information about THC content and the source of the hemp. This includes a QR code that links to the product’s certificate of analysis, which provides detailed information on cannabinoid content and the absence of harmful contaminants.
- Future Considerations – The evolving nature of hemp legislation at both federal and state levels suggests that additional regulations concerning the production and sale of hemp and its derivatives, including minor cannabinoids, may be forthcoming. Stakeholders are encouraged to stay informed on legislative developments to ensure compliance and leverage market opportunities in Florida’s hemp industry.
Psychedelics
Florida follows the federal classification for controlled substances, which lists most psychedelics under Schedule I. This classification is found under Florida Statutes § 893.03, indicating that substances like LSD, psilocybin, and MDMA have no accepted medical use and a high potential for abuse according to both state and federal law.
- Ketamine Laws – Unlike many psychedelics, ketamine is classified as a Schedule III substance under Florida law, acknowledging its potential for medical use. It is primarily used in anesthesia but has been recognized for its rapid-acting antidepressant effects. Under Florida Statutes § 893.03, ketamine can be prescribed and administered under strict medical supervision.
- Telehealth: Florida has adopted telehealth regulations that allow for the prescription of controlled substances, including ketamine, through telehealth services. This is detailed in Florida Statutes § 456.47, which outlines the conditions under which controlled substances may be prescribed via telehealth. Providers must conduct a physical examination or have a prior established relationship with the patient, ensuring compliance with all applicable laws for patient safety.
- State Right to Try – Florida’s Right to Try Act, codified in Florida Statute § 499.0295, allows eligible patients with serious conditions to access investigational drugs, biological products, or devices that have completed phase one of a clinical trial but have not been approved for general use by the U.S. Food and Drug Administration and remain under FDA investigation. This law potentially opens pathways for access to certain psychedelic therapies under controlled conditions.
- State Religious Exemptions – Regarding the use of psychedelics for religious purposes, Florida does not have specific exemptions; however, federal rulings such as the UDV Church’s Supreme Court victory allow the use of ayahuasca for religious ceremonies. Florida residents partaking in these practices typically rely on these federal protections to justify their use under religious freedom.
Check Other States Licensing Guide
- Adult Use
- Medical
- Limited Medical
- Illegal
Where to Find Us
Address
Contact INFO
PHONE:Â 786-526-1155
EMAIL:Â info@mrcannabislaw.com
